Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Head and Neck Neoplasms 3Breast Neoplasms, Male 2Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Meningioma 1Meningeal Carcinomatosis 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Infections 1Graft vs Host Disease 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Body Weight Changes 1

Interventions

Sorafenib 9Radiofrequency Ablation 7Oxaliplatin 7Fluorouracil 6Doxorubicin 6Neoadjuvant Therapy 5toripalimab 4lenvatinib 4Injections 4Chemotherapy, Adjuvant 4Bevacizumab 4sintilimab 3pembrolizumab 3Ultrasonography 3Thalidomide 3Leucovorin 3Irinotecan 3Cisplatin 3tislelizumab 2durvalumab 2camrelizumab 2anlotinib 2Walking Speed 2Standard of Care 2Radiosurgery 2Oncolytic Virotherapy 2Metformin 2Liver Transplantation 2Laparoscopy 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Liver Neoplasms × Immunoenzyme Techniques × Clear all
NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
54 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡